These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 4212264)
1. Preparation of vaccines--cell substrates. Perkins FT Adv Exp Med Biol; 1972; 31(0):187-96. PubMed ID: 4212264 [No Abstract] [Full Text] [Related]
2. The need for a standardised cell substrate for virus vaccine production. Perkins FT Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315 [No Abstract] [Full Text] [Related]
3. Origin of endogenous and exogenous agents in cell cultures. Hopps HE In Vitro; 1974; 10(5-6):243-6. PubMed ID: 4217763 [No Abstract] [Full Text] [Related]
4. Viral vaccines: various cell substrates and long-term prospective studies. Kirschstein RL; Petricciani JC Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515 [No Abstract] [Full Text] [Related]
5. Characteristics of primary cultures and diploid cells--technology of production. Holper JC Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359 [No Abstract] [Full Text] [Related]
6. Tissue and medium antigens in vaccines. Coriell LL Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862 [No Abstract] [Full Text] [Related]
7. Development of a diploid cell line from fetal rhesus monkey lung for virus vaccine production. Wallace RE; Vasington PJ; Petricciani JC; Hopps HE; Lorenz DE; Kadanka Z In Vitro; 1973; 8(5):323-32. PubMed ID: 4348695 [No Abstract] [Full Text] [Related]
8. The need for a standardised cell substrate for virus vaccine production. Perkins FT Jpn J Med Sci Biol; 1971 Oct; 24(5):329-35. PubMed ID: 5003824 [No Abstract] [Full Text] [Related]
9. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates. Deinhardt F Natl Cancer Inst Monogr; 1968 Dec; 29():327-31. PubMed ID: 4305431 [No Abstract] [Full Text] [Related]
10. Comparison of various methods for preparation of viral serological antigens from infected cell cultures. Schmidt NJ; Lennette EH Appl Microbiol; 1971 Feb; 21(2):217-26. PubMed ID: 4994353 [TBL] [Abstract][Full Text] [Related]
11. Vaccines produced in heteroploid cell lines--discussion. Hull RN Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366 [No Abstract] [Full Text] [Related]
12. Use of cell cultures in vaccine production: diploid and stable cell cultures. Matchett A J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214 [No Abstract] [Full Text] [Related]
13. The laboratory control of viral vaccines. Perkins FT Prog Immunobiol Stand; 1967; 3():225-31. PubMed ID: 4985509 [No Abstract] [Full Text] [Related]
14. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells. Huygelen C; Peetermans J; Prinzie A Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707 [No Abstract] [Full Text] [Related]
15. Markers for measles virus. II. Tissue culture properties. Schumacher HP; Albrecht P; Tauraso NM Arch Gesamte Virusforsch; 1972; 36(3):296-310. PubMed ID: 4623186 [No Abstract] [Full Text] [Related]
16. Suggested criteria for the acceptability of a passaged diploid cell population as substrate for virus vaccine production. Perkins FT Jpn J Med Sci Biol; 1971 Oct; 24(5):336-41. PubMed ID: 5003825 [No Abstract] [Full Text] [Related]